Advances in treatment: Immunoglobulin A nephropathy

Seminars in Nephrology

Volumn 16, Issue 6, 1996, Pages 511-516

  Hogg, Ronald J ^a   Waldo, Bryson ^a  

^a MEDICAL CITY DALLAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; ENALAPRIL; FISH OIL; HEPARIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; OMEGA 3 FATTY ACID; PHENYTOIN; PREDNISONE; TETRACYCLINE; UNCLASSIFIED DRUG; WARFARIN;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FAILURE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEROID THERAPY; TONSILLECTOMY;

ADRENAL CORTEX HORMONES; ADULT; CHILD; CONTROLLED CLINICAL TRIALS; FEMALE; FISH OILS; FORECASTING; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; PROGNOSIS;

EID: 0029963351     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Noel LH, Droz D, Gascon M, et al: Primary IgA nephropalhy: From the first-described cases to the present. Semin Nephrol 7:351-354, 1987
2. Velo M, Lozano L, Egido J, et al: Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain. Semin Nephrol 7:346-350, 1987
3. D'Amico G, Colasanti G, Barbiano di Belgioioso G, et al: Long-term follow-up of IgA mesangial nephropathy: Clinico-histological study in 374 patients. Semin Nephrol 7:355-358, 1987
4. Clarkson AR, Woodroffe AJ, Aarons I: IgA nephropathy in patients followed for at least ten years. Semin Nephrol 7:377-378, 1987
5. Yoshikawa N, Ito H, Nakamura H: Prognostic indicators in childhood IgA nephropathy. Nephron 60:60-67, 1992
6. Berg UB, Widstam-Attorps UC: Follow-up of renal function and urinary protein excretion in childhood IgA nephropathy. Pediatr Nephrol 7:123-129, 1993
7. Hogg RJ, Suva FG, Wyatt RJ, et al: Prognostic indicators in children with IgA nephropathy-Report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 8:15-20, 1994
8. Habib R, Niaudet P, Levy M: Schonlein-Henoch purpura nephritis and IgA nephropathy, chapter 15, in Tisher CC, Brenner BM (eds): Renal Pathology: With Clinical and Functional Correlations, 2nd ed. Philadelphia, PA, Lippincott, 1994, pp 472-523
9. Nicholls K, Becker G, Walker R, et al: Plasma exchange in progressive IgA nephropathy. J Clin Apheresis 5:128-132, 1990
10. Lai KN, Lai FM, Leung ACT, et al: Plasma exchange in patients with rapidly progressive idiopathic IgA nephropathy: A report of two cases and review of literature. Am J Kidney Dis 10:66-70, 1987
11. Roccatello D, Ferro M, Coppo R, et al: Treatment of rapidly progressive igA nephropathy. Contrib Nephrol 111:177-183, 1995
12. Egido J, Rivera F, Sancho J, et al: Phenytoin in IgA nephropathy: A long-term controlled trial. Nephron 38:30-39, 1984
13. Clarkson AR, Seymour AE, Woodroffe AJ, et al: Controlled trial of phenytoin therapy in IgA nephropathy. Clin Nephrol 13:215-218, 1980
14. Tomino Y, Sakai H, Miura M, et al: Effect of danazol on solubilization of immune deposits in patients with IgA nephropathy. Am J Kidney Dis 4:135-139, 1984
15. Kincaid-Smith PS, Nicholls K: Mesangial IgA nephropathy. Am J Kidney Dis 3:90-102, 1983
16. García-Hoyo LL, Blasco R, Egido J, et al: Tonsillectomy: A possible therapeutic approach in patients with IgA nephropathy and episodes of macroscopic hematuria. Kidney Int 30:134A, 1986
17. Bene MC, de Ligny BH, Kessler M, et al: Confirmation of tonsillar anomalies in IgA nephropathy: A multicenter study. Nephron 58:425-428, 1991
18. Rekola S, Bergstrand A, Bucht H: Deterioration rate in hypertensive IgA nephropathy: Comparison of a converting enzyme inhibitor and β-blocking agents. Nephron 59:57-60, 1991
19. Cattran DC, Greenwood C, Ritchie S: Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254, 1994
20. Bannister KM, Weaver A, Clarkson AR, et al: Effect of Angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy. Contrib Nephrol 111:184-193, 1995
21. Waldo FB, Wyatt RJ, Kelly DR, et al: Treatment of IgA nephropathy in children: Efficacy of alternate-day oral prednisone. Pediatr Nephrol 7:529-532, 1993
22. Kobayashi Y, Hiki Y, Kokubo T, et al: Steroid therapy in IgA nephropathy: A 10-year follow-up study. Proc IgA Neph Intl Symp, Adelaide, Australia, 1994, abstr 1A
23. Welch TR, Fryer C, Shely E, et al: Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 121:474-477, 1992
24. Julian BA, Barker C: Alternate-day prednisone therapy in IgA nephropathy: Preliminary analysis of a prospective, randomized, controlled trial. Contrib Nephrol 104:198-206, 1993
25. Nicholls K, Kincaid-Smith P, Becker G: Prednisolone decreases haematuria in IgA nephropathy. Proceedings of the 30th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, March 1994, abstr 39A
26. Donadio JV Jr, Bergstralh EJ, Offord DP, et al: A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331:1194-1198, 1994
27. Hamazaki T, Tateno S, Shishido H: Eicosapentaenoic acid and IgA nephropathy. Lancet 1:1017-1018, 1984
28. Cheng IKP, Chan PCK, Chan MK: The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis. Nephrol Dial Transplant 5:241-246, 1990
29. Bennett WM, Walker RB, Kincaid-Smith P: Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial. Clin Nephrol 31:128-131, 1989
30. Pettersson EE, Rekola S, Berglund L, et al: Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: A prospective, double-blind, randomized study. Clin Nephrol 41:183-190, 1994
31. Hogg RJ for the SPNSG: A randomized, placebo-controlled, multicenter trial evaluating a) alternate day prednisone b) fish oil supplements in young patients with IgA nephropathy. Am J Kidney Dis 26:792-796, 1995